A retrospective cohort study comparing periodontal regeneration using fibroblast growth factor‐2 versus autologous bone graft
Journal of Periodontology · 2026
DOI: 10.1002/jper.70060 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Periodontology, 2026. Verfasst von Toshiki Matsumoto und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology-Periodontal Science, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, J…. Hauptthemen laut MEDLINE: Fibroblast Growth Factor 2, Bone Transplantation, Guided Tissue Regeneration, Periodontal. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Fibroblast growth factor‐2 (FGF‐2) is a novel agent utilized in periodontal regeneration therapy. However, its clinical efficacy compared with autologous bone graft (ABG), a long‐established treatment, remains unclear. This study aimed to compare the clinical outcomes of FGF‐2 and ABG and to assess the impact of patient background factors on outcomes when using FGF‐2.
Methods
We collected the subjects from January 2013 to September 2023. Clinical outcomes included the vertical bone defect improvement rate (VBDIR) and the probing pocket depth improvement (PPDI). Clinical outcomes between the two groups were compared using analysis of covariance (ANCOVA), adjusting for age, sex, smoking history, and hypertension. Additionally, a multilevel linear analysis was performed to assess factors influencing outcomes in FGF‐2.
Results
A total of 180 sites from 141 patients (FGF‐2: 150 sites; ABG: 30 sites) were evaluated. Both VBDIR and PPDI significantly improved postoperatively in both groups. There were no significant differences in clinical outcomes between FGF‐2 and ABG. In FGF‐2, smoking history was positively associated, while the preoperative bone defect angle (BDA) was negatively associated with clinical outcomes.
Conclusions
FGF‐2 might exhibit clinical outcomes comparable to those of ABG, suggesting it is a clinically viable alternative for vertical bone defects. When using FGF‐2, patient‐specific factors such as smoking history and preoperative BDA should be considered carefully. The name in the trial registry A survey of clinical practice and evaluation of treatment outcomes of periodontal regenerative therapy using REGROTH at Okayama University Hospital Plain Language Summary This retrospective study compared the clinical outcomes of fibroblast growth factor‐2 (FGF‐2), a novel therapeutic agent, with autologous bone graft (ABG), a long‐established treatment. A total of 180 sites from 141 patients (150 FGF‐2 sites, 30 ABG sites) were evaluated based on the vertical bone defect improvement rate (VBDIR) and the probing pocket depth improvement (PPDI). Using analysis of covariance (ANCOVA), adjusted for patient background factors such as age, sex, smoking history, and hypertension, no significant differences in clinical outcomes were observed between the two treatment groups. Further multilevel linear analysis focusing on the FGF‐2 group revealed that smoking history was positively associated, while preoperative bone defect angle (BDA) was negatively associated with clinical outcomes. These findings suggest that FGF‐2 may offer clinical benefits comparable to ABG in treating vertical bone defects while having the added advantage of being less invasive. However, when using FGF‐2, dentists should consider individual patient factors such as smoking habits and defect morphology, as these may influence treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathophysiology-Periodontal Science, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
- Department of Periodontics and Endodontics, Division of Dentistry, Okayama University Hospital, Okayama, Japan.
- The Center for Graduate Medical Education (Dental Division), Okayama University Hospital, Okayama, Japan.
Zitieren
APA
Matsumoto, T., Nakamura, S., Ito-Shinoda, Y., Sakamoto, M., Ishii, T., Nonomura, Y., Ideguchi, H., Okubo, K., Takeuchi-Hatanaka, K., Omori, K., Yamamoto, T., & Takashiba, S. (2026). A retrospective cohort study comparing periodontal regeneration using fibroblast growth factor‐2 versus autologous bone graft. Journal of Periodontology. https://doi.org/10.1002/jper.70060
Vancouver
Matsumoto T, Nakamura S, Ito-Shinoda Y, Sakamoto M, Ishii T, Nonomura Y, et al. A retrospective cohort study comparing periodontal regeneration using fibroblast growth factor‐2 versus autologous bone graft. Journal of Periodontology. 2026. doi:10.1002/jper.70060
BibTeX
@article{Matsumoto2026,
author = {Matsumoto, Toshiki and Nakamura, Shin and Ito-Shinoda, Yuki and Sakamoto, Mai and Ishii, Takayuki and Nonomura, Yasuki and Ideguchi, Hidetaka and Okubo, Keisuke and Takeuchi-Hatanaka, Kazu and Omori, Kazuhiro and Yamamoto, Tadashi and Takashiba, Shogo},
title = {A retrospective cohort study comparing periodontal regeneration using fibroblast growth factor‐2 versus autologous bone graft},
journal = {Journal of Periodontology},
year = {2026},
doi = {10.1002/jper.70060}
}
EUVIMED